# Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix

> clinical trial · VERIFIED · 2026-08-12

Status: ACTIVE_NOT_RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Carcinomas

- Company: M.D. Anderson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05063916

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.